TY  - CONF

T1  - The addition of zoledronic acid to combination chemotherapy decreases circulating serum levels of vascular endothelial growth factor (VEGF) in early breast cancer

JO  - BONE

PY  - 2011/01/01

AU  - Winter MC

AU  - Evans A

AU  - Holen I

AU  - Coleman RE

ED  - 

DO  - DOI: 10.1016/j.bone.2010.10.082

VL  - 48

IS  - 1

SP  - S30

EP  - S31

Y2  - 2024/12/21

ER  -